Transformation of ALK expression and PD-L1 0% to PD-L1 90% only after surgery: the need for rebiopsy in lung cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Transformation of ALK expression and PD-L1 0% to PD-L1 90% only after surgery: the need for rebiopsy in lung cancer patients

Published:2019-01 Issue: Volume:Volume 12 Page:15-20
ISSN:1179-142X
Container-title:International Medical Case Reports Journal
language:en
Short-container-title:IMCRJ

Author:

Kosmidis Christoforos^ORCID,Koimtzis Georgios^ORCID,Giannakidis Dimitrios^ORCID,Tteralli Nikos,Mantalovas Stylianos,Tsakalidis Alexandros^ORCID,Tsopouridou Konstantina,Atmatzidis Stefanos,Liavas Lazaros,Zarogoulidis Paul

Publisher

Informa UK Limited

Subject

General Medicine

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biopsy and re-biopsy for PD-L1 expression in NSCLC. association between PD-L1 and checkpoint inhibitor efficacy through treatment in NSCLC. A pilot study;Expert Review of Respiratory Medicine;2021-10-12

2. Effective early diagnosis for NSCLC: an algorithm;Expert Review of Respiratory Medicine;2021-08-23

3. Emergence of lung cancer with a low PD-L1 expression level after the administration of immune check point inhibitor for lung adenocarcinoma with a high PD-L1 expression level: A case report;Annals of Medicine and Surgery;2020-08

4. EBUS-TNBA 22G samples: Comparison of PD-L1 expression between DAKO and BIOCARE®;Journal of Cancer;2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP